BALYASNY ASSET MANAGEMENT LLC 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 06:01 am Sale |
2024-09-30 | 13G | Mersana Therapeutics, Inc. MRSN |
BALYASNY ASSET MANAGEMENT LLC | 535,819 0.440% |
-9,162,328 (-94.48%) |
Filing |
| 2024-02-14 07:22 am Purchase |
2023-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
BALYASNY ASSET MANAGEMENT LLC | 9,698,147 8.040% |
9,698,147 (New Position) |
Filing |